Allcyte logo — Allcyte tests drugs in human tissue for personalized medicin...

Allcyte

Allcyte tests drugs in human tissue for personalized medicine and helps focus drug development efforts.

Founded 2017 Austria Austria 2-10 employees Grant Total: $6.00M Biotechnology, Health Care +2

General Information

Company Name Allcyte
Founded Year 2017
Location Austria Austria
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical +1
Funding Stage Grant
Social

Get notified when Allcyte moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Allcyte

Allcyte is a biotechnology startup based in Austria that specializes in conducting functional drug testing on human tissue. Established in 2017, the company's mission is to revolutionize personalized medicine for cancer patients and healthcare providers. Leveraging its cutting-edge Pharmacoscopy high-content imaging platform and AI-driven image analysis pipelines, Allcyte assists pharmaceutical firms in focusing their drug development efforts on the most suitable molecules and indications. The startup's approach enables them to measure individual cell characteristics directly in unaltered patient samples, with minimal modifications and sample requirements. Notably, EIT Health recently provided grant investment to support Allcyte's groundbreaking work on 09 July 2020. By enabling the testing of drugs in human tissue, Allcyte is playing a crucial role in driving the advancement of personalized medicine and refining the drug development landscape within the biotechnology and pharmaceutical industries.

Taxonomy: personalized medicine, drug testing, cancer, Pharmacoscopy, high-content imaging, AI-assisted, primary human material, pharmaceutical, image-based measurement, statistics, biomedical decisions

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 09 Jul 2020
Seed Round •••••• 5
Investor Investor Investor Investor Investor
01 Jul 2020

Allcyte Alternatives & Competitors

Allcyte vs

Quantiscope PBC leverages image-based generative AI to make drugs better, faster and safer.

Grant
2 employees
Biotechnology
Allcyte vs

Harnessing image-based screening and target protein identification to accelerate innovative drug dev...

Series C
Biotechnology, Health Care
Allcyte vs

Background Screening Specialists Providing Intelligence for Smart Hiring Decisions. We are a PBSA Ac...

13 employees
Human Resources

FAQ About Allcyte

Allcyte tests drugs in human tissue for personalized medicine and helps focus drug development efforts.
Allcyte was founded in 2017.
Allcyte is headquartered in Austria.
Allcyte operates in the following industries: Biotechnology, Health Care, Pharmaceutical, Machine Learning.
Allcyte has approximately 2-10 employees.
Allcyte has completed 2 funding rounds, raising a total of $6.00M. The latest funding stage is Grant.
Top alternatives and competitors to Allcyte include QUANTiSCOPE®, Spark Biopharma, Hire Image, A Division of Orange Tree, Probetex Inc, Medterials, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Allcyte and QUANTiSCOPE® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Allcyte and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy